Clinical trial
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body…
NCT00388180 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00388180 |
|---|---|
| Title | An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation |
| Official title | A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of 12-week Treatment With GW590735X (20ug) or GW501516X (10mg) Relative to Placebo on Measures of Adiposity and Inflammation in Overweight and Obese Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypercholesterolemia, Dyslipidaemias, Obesity |
| Intervention type | Drug |
| Interventions | GW501516, GW590735 |
| Enrollment | 71 |
| Start date | Dec 1, 2004 |
| First posted | Oct 16, 2006 |
| Last update posted | Mar 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: